Redesca Hp 150 mg

REDESCA HP 150 MG is an intravenous solution containing enoxaparin sodium, a low-molecular-weight heparin. It is commonly used for preventing and treating blood clots. This medication is manufactured by Shenzhen Techdow Pharmaceutical Co., Ltd.

REDESCA HP 150 MG is primarily used for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used to prevent blood clots in patients undergoing certain types of surgery or those who are bedridden. Enoxaparin sodium works by thinning the blood, reducing the risk of clot formation.

Common effects of REDESCA HP 150 MG may include bruising, bleeding, and pain at the injection site. Some users may experience nausea or dizziness. Severe allergic reactions are rare but possible. Always consult a healthcare provider if you experience unusual symptoms.

REDESCA HP 150 MG should be handled with care to avoid contamination. It is important to follow proper administration procedures to minimize the risk of infection or injury. Store the solution at the recommended temperature and protect it from light. Do not use if the solution appears cloudy or contains particles.

REDESCA HP 150 MG may interact with other blood-thinning medications, increasing the risk of bleeding. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain foods may also affect the efficacy of enoxaparin sodium.